Herophilus
Founded 2017 · 6 employees on LinkedIn · 2 known investors
Herophilus develops neurological drug discovery by combining human brain models, scaled biology, and machine learning to identify and develop novel drugs for complex brain diseases. It operates in the biotech and neuroscience drug development space.
Investors · 2
Frequently asked questions
- What does Herophilus do?
- Herophilus develops neurological drug discovery by combining human brain models, scaled biology, and machine learning to identify and develop novel drugs for complex brain diseases. It operates in the biotech and neuroscience drug development space.
- Who are Herophilus's investors?
- Herophilus's investors include Kinled Holding, Boom Capital Ventures.